| Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care (NCT06660719) | Shin Poong Pharmaceutical Co. Ltd. | 2025-02-14 |
| Efficacy and Safety of SPC1001 in Patients With Essential Hypertension (NCT06826872) | Shin Poong Pharmaceutical Co. Ltd. | 2024-06-12 |
| Pivotal Study to Evaluate Efficacy and Safety of SP5M002 Inj. as Compared to Synovian Inj. in Patients With Mild to Moderate Knee Osteoarthritis (NCT06399042) | Shin Poong Pharmaceutical Co. Ltd. | 2023-06-14 |
| Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (NCT05633420) | Shin Poong Pharmaceutical Co. Ltd. | 2022-07-24 |
| Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension (NCT06212648) | Shin Poong Pharmaceutical Co. Ltd. | 2022-03-25 |
| A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu Tab (NCT06225635) | Shin Poong Pharmaceutical Co. Ltd. | 2022-01-01 |
| The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3) (NCT05084911) | Shin Poong Pharmaceutical Co. Ltd. | 2021-10-18 |
| Pivotal Study to Evaluate Efficacy and Safety of SP5M001 Inj. as Compared to Synovian Inj. in Patients With Mild to Moderate Knee Osteoarthritis (NCT06307847) | Shin Poong Pharmaceutical Co. Ltd. | 2021-04-14 |
| The Safety and Efficacy of Pyronaridine-artesunate (Pyramax® or Artecom®)in COVID-19 Patients (NCT04701606) | Shin Poong Pharmaceutical Co. Ltd. | 2021-03-29 |
| Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19 (NCT04532931) | Shin Poong Pharmaceutical Co. Ltd. | 2020-09-03 |
| The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (NCT04475107) | Shin Poong Pharmaceutical Co. Ltd. | 2020-07-09 |
| Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SP-8008 (NCT04770194) | Shin Poong Pharmaceutical Co. Ltd. | 2019-10-01 |
| Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA (NCT04479449) | Shin Poong Pharmaceutical Co. Ltd. | 2019-03-18 |
| Pyramax in Asymptomatic Carriers of P. Falciparum Monoinfections (NCT03814616) | Shin Poong Pharmaceutical Co. Ltd. | 2018-10-03 |